HK Stock MarketDetailed Quotes

TRAD CHI MED (00570)

Watchlist
  • 1.395
  • +0.010+0.72%
15min DelayNot Open Aug 25 16:01 CST
7.02BMarket Cap-18.60P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TRAD CHI MED (00570) Income Statement

Cumulative·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
Total Revenue
-10.69%14.74B
-11.00%7.46B
-8.90%16.51B
-9.86%8.39B
+26.69%18.12B
+57.37%9.30B
-24.92%14.30B
-27.46%5.91B
+28.68%19.05B
+22.45%8.15B
+3.39%14.81B
-4.06%6.66B
+27.20%14.32B
+27.02%6.94B
+35.03%11.26B
+40.07%5.46B
+27.63%8.34B
+21.88%3.90B
+76.12%6.53B
+124.97%3.20B
Operating Revenue
-10.69%14.74B
-11.00%7.46B
-8.90%16.51B
-9.86%8.39B
+26.69%18.12B
+57.37%9.30B
-24.92%14.30B
-27.46%5.91B
+28.68%19.05B
+22.45%8.15B
+3.39%14.81B
-4.06%6.66B
+27.20%14.32B
+27.02%6.94B
+35.03%11.26B
+40.07%5.46B
+27.63%8.34B
+21.88%3.90B
+76.12%6.53B
+124.97%3.20B
Cost of Revenue
+11.55%-7.65B
+11.46%-3.83B
+2.19%-8.65B
+4.86%-4.32B
-24.51%-8.85B
-53.56%-4.54B
+1.63%-7.11B
+5.94%-2.96B
-27.17%-7.22B
-19.26%-3.15B
+1.13%-5.68B
+4.05%-2.64B
-13.42%-5.75B
-8.66%-2.75B
-37.41%-5.07B
-46.34%-2.53B
-34.28%-3.69B
-26.64%-1.73B
-81.95%-2.75B
-141.54%-1.37B
Cost of Goods Sold
+11.55%-7.65B
+11.46%-3.83B
+2.19%-8.65B
+4.86%-4.32B
-24.51%-8.85B
-53.56%-4.54B
+1.63%-7.11B
+5.94%-2.96B
-27.17%-7.22B
-19.26%-3.15B
+1.13%-5.68B
+4.05%-2.64B
-13.42%-5.75B
-8.66%-2.75B
-37.41%-5.07B
-46.34%-2.53B
-34.28%-3.69B
-26.64%-1.73B
-81.95%-2.75B
-141.54%-1.37B
Gross Profit
-9.74%7.09B
-10.51%3.63B
-15.29%7.86B
-14.64%4.06B
+28.84%9.27B
+61.19%4.76B
-39.15%7.20B
-41.00%2.95B
+29.62%11.83B
+24.54%5.00B
+6.42%9.13B
-4.07%4.02B
+38.46%8.58B
+42.87%4.19B
+33.15%6.19B
+35.07%2.93B
+22.81%4.65B
+18.33%2.17B
+72.11%3.79B
+114.04%1.83B
Operating Expense
+5.36%-6.79B
+5.22%-3.50B
+11.82%-7.18B
+8.01%-3.69B
-31.94%-8.14B
-62.27%-4.01B
+33.40%-6.17B
+34.30%-2.47B
-34.31%-9.26B
-23.21%-3.76B
-9.89%-6.90B
-1.24%-3.05B
-48.56%-6.28B
-61.88%-3.02B
-41.98%-4.23B
-42.36%-1.86B
-19.75%-2.98B
-12.46%-1.31B
-50.55%-2.49B
-91.92%-1.16B
Selling Expenses
+8.57%-4.95B
+7.13%-2.56B
+15.37%-5.42B
+13.63%-2.75B
-39.08%-6.40B
-85.61%-3.19B
+39.28%-4.60B
+43.58%-1.72B
-35.71%-7.58B
-24.58%-3.04B
-9.35%-5.59B
+0.43%-2.44B
-49.51%-5.11B
-64.70%-2.45B
-40.21%-3.42B
-45.71%-1.49B
-23.81%-2.44B
-16.59%-1.02B
-64.63%-1.97B
-96.84%-876.91M
Administrative Expenses
-5.46%-1.12B
+2.27%-500.54M
-1.38%-1.06B
-10.20%-512.15M
-10.47%-1.04B
-15.72%-464.75M
+3.08%-944.40M
-5.77%-401.61M
-37.77%-974.45M
-13.79%-379.70M
-3.07%-707.28M
-10.10%-333.68M
-24.24%-686.19M
-37.03%-303.08M
-58.05%-552.29M
-33.78%-221.17M
-5.90%-349.45M
+11.74%-165.32M
-21.06%-329.99M
-51.96%-187.32M
Research and Development Expenses
+14.18%-511.47M
+4.40%-256.12M
+13.07%-596.01M
+14.57%-267.93M
-12.06%-685.63M
+1.23%-313.61M
+11.90%-611.83M
-7.75%-317.53M
-26.15%-694.44M
-20.13%-294.70M
-18.64%-550.47M
-17.38%-245.32M
-33.89%-464.00M
-40.19%-209.00M
-71.42%-346.54M
-22.61%-149.09M
-8.20%-202.16M
-21.56%-121.60M
-66.33%-186.83M
---100.03M
Impairment and Provision
-99.49%-212.57M
-17.07%-185.88M
-1037.67%-106.55M
-232.37%-158.77M
+7.02%-9.37M
-29.33%-47.77M
+27.42%-10.07M
+20.19%-36.94M
+74.17%-13.88M
-39.65%-46.28M
-198.32%-53.73M
+36.19%-33.14M
-119.87%-18.01M
-1190.01%-51.94M
+613.15%90.65M
---4.03M
--12.71M
----
----
----
-Impairment Losses of Other Assets
-99.49%-212.57M
-17.07%-185.88M
-1037.67%-106.55M
-232.37%-158.77M
+7.02%-9.37M
-29.33%-47.77M
+27.42%-10.07M
+20.19%-36.94M
+74.17%-13.88M
-39.65%-46.28M
-198.32%-53.73M
+36.19%-33.14M
-119.87%-18.01M
-1190.01%-51.94M
+613.15%90.65M
---4.03M
--12.71M
----
----
----
Special Items of Operating Income
-65.79%-565.70M
-1255.45%-171.34M
-215.94%-341.22M
-78.55%14.83M
+712.16%294.30M
-24.19%69.13M
-80.79%36.24M
+18.56%91.19M
-28.22%188.63M
-47.42%76.91M
+61.93%262.77M
+74.22%146.27M
-13.61%162.28M
+26.19%83.96M
+69.32%187.83M
+158.07%66.53M
+49.20%110.94M
-11.79%25.78M
-47.21%74.35M
-28.97%29.23M
Operating Profit
-180.13%-268.90M
-109.28%-35.69M
-76.49%335.59M
-52.76%384.58M
+34.11%1.43B
+42.82%814.05M
-61.34%1.06B
-56.68%569.97M
+10.54%2.75B
+18.73%1.32B
+1.22%2.49B
-11.61%1.11B
+14.13%2.46B
+10.62%1.25B
+20.69%2.16B
+27.87%1.13B
+29.76%1.79B
+26.86%886.29M
+99.30%1.38B
+139.92%698.65M
Financing Cost
+42.21%-99.13M
+43.99%-47.20M
+13.82%-171.54M
+20.07%-84.27M
+9.81%-199.05M
-6.97%-105.44M
+0.60%-220.70M
+10.34%-98.57M
+9.25%-222.03M
+2.63%-109.93M
+18.73%-244.67M
-1.25%-112.89M
-2.99%-301.05M
+10.28%-111.51M
-32.22%-292.30M
-45.87%-124.28M
-201.09%-221.07M
-149.40%-85.20M
---73.42M
---34.16M
Share of Profits of Associates
+79.26%-197.00K
+94.62%-47.00K
+74.32%-950.00K
+51.34%-874.00K
-6.32%-3.70M
-9.51%-1.80M
+67.63%-3.48M
+79.00%-1.64M
+32.29%-10.75M
-60.66%-7.81M
-214.27%-15.87M
-194.01%-4.86M
+28.13%-5.05M
+72.95%-1.65M
-479.48%-7.03M
-229.74%-6.11M
+317.12%1.85M
-316.98%-1.85M
+127.12%444.00K
--854.00K
Pretax Profit
-325.76%-368.23M
-127.70%-82.94M
-86.68%163.11M
-57.64%299.43M
+45.76%1.22B
+50.46%706.81M
-66.67%840.11M
-60.78%469.77M
+13.01%2.52B
+20.96%1.20B
+3.50%2.23B
-13.16%990.37M
+16.05%2.15B
+13.72%1.14B
+18.47%1.86B
+25.48%1.00B
+20.20%1.57B
+20.12%799.24M
+89.19%1.30B
+128.48%665.35M
Tax
+36.87%-89.86M
+31.03%-58.82M
-182.98%-142.34M
+5.08%-85.29M
+243.97%171.54M
-86.30%-89.85M
+69.98%-119.14M
+74.78%-48.23M
-7.42%-396.86M
-19.40%-191.24M
+3.11%-369.45M
+13.90%-160.17M
-31.64%-381.32M
-10.45%-186.03M
-13.24%-289.67M
-23.41%-168.42M
-17.74%-255.80M
-13.47%-136.47M
-82.41%-217.26M
-156.04%-120.27M
Net Profit
-2305.43%-458.09M
-166.20%-141.76M
-98.51%20.77M
-65.29%214.14M
+93.64%1.40B
+46.36%616.96M
-66.05%720.97M
-58.13%421.54M
+14.12%2.12B
+21.26%1.01B
+4.93%1.86B
-13.02%830.20M
+13.16%1.77B
+14.38%954.44M
+19.49%1.57B
+25.90%834.45M
+20.70%1.31B
+21.59%662.77M
+68.70%1.09B
+139.84%545.08M
Profit from Continuing Operations
-2305.43%-458.09M
-166.20%-141.76M
-98.51%20.77M
-65.29%214.14M
+93.64%1.40B
+46.36%616.96M
-66.05%720.97M
-58.13%421.54M
+14.12%2.12B
+21.26%1.01B
+4.93%1.86B
-13.02%830.20M
+13.16%1.77B
+14.38%954.44M
+19.49%1.57B
+25.90%834.45M
+20.70%1.31B
+21.59%662.77M
+90.60%1.09B
+123.18%545.08M
Minority Interests
-248.45%-116.02M
-1169.60%-33.84M
-130.03%-33.30M
-91.72%3.16M
+354.75%110.87M
+380.91%38.22M
-122.84%-43.52M
-89.66%7.95M
-3.46%190.57M
-21.72%76.85M
+6.59%197.39M
+3.00%98.18M
+44.66%185.18M
+28.56%95.32M
-9.21%128.01M
+15.58%74.14M
+17.88%141.00M
+18.13%64.15M
+548.20%119.61M
+841.20%54.30M
Net Income to Parent Company
-732.68%-342.07M
-151.15%-107.92M
-95.79%54.07M
-63.55%210.98M
+68.11%1.29B
+39.93%578.74M
-60.45%764.49M
-55.52%413.59M
+16.21%1.93B
+27.02%929.83M
+4.73%1.66B
-14.79%732.02M
+10.36%1.59B
+13.00%859.12M
+22.95%1.44B
+27.01%760.31M
+21.05%1.17B
+21.97%598.62M
+54.56%966.93M
+109.20%490.78M
Net Income to Common Stockholders
-732.68%-342.07M
-151.15%-107.92M
-95.79%54.07M
-63.55%210.98M
+68.11%1.29B
+39.93%578.74M
-60.45%764.49M
-55.52%413.59M
+16.21%1.93B
+27.02%929.83M
+4.73%1.66B
-14.79%732.02M
+10.36%1.59B
+13.00%859.12M
+22.95%1.44B
+27.01%760.31M
+21.05%1.17B
+21.97%598.62M
+54.56%966.93M
+109.20%490.78M
Basic EPS
-734.58%-0.07
-151.07%-0.02
-95.81%0.01
-63.53%0.04
+68.12%0.26
+39.95%0.11
-60.45%0.15
-55.53%0.08
+16.20%0.38
+26.96%0.18
+4.72%0.33
-14.77%0.15
+5.70%0.32
+3.33%0.17
+12.99%0.30
+22.21%0.17
+21.54%0.26
+23.04%0.14
+28.05%0.22
+41.13%0.11
Diluted EPS
-734.58%-0.07
-151.07%-0.02
-95.81%0.01
-63.53%0.04
+68.12%0.26
+39.95%0.11
-60.45%0.15
-55.53%0.08
+16.20%0.38
+26.96%0.18
--0.33
--0.15
----
----
----
----
--0.26
+23.04%0.14
----
+41.13%0.11
Deadline
Dec 31, 2025
Jun 30, 2025
Dec 31, 2024
Jun 30, 2024
Dec 31, 2023
Jun 30, 2023
Dec 31, 2022
Jun 30, 2022
Dec 31, 2021
Jun 30, 2021
Dec 31, 2020
Jun 30, 2020
Dec 31, 2019
Jun 30, 2019
Dec 31, 2018
Jun 30, 2018
Dec 31, 2017
Jun 30, 2017
Dec 31, 2016
Jun 30, 2016
Accounting Standard
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2025/FY2025/H12024/FY2024/H12023/FY2023/H12022/FY2022/H12021/FY2021/H12020/FY2020/H12019/FY2019/H12018/FY2018/H12017/FY2017/H12016/FY2016/H1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +9.31%
Sample Name
Sample Code
 +9.05%
Sample Name
Sample Code
 +5.41%
4
PETROCHINA
00857
+2.24%
5
SHANGHAI PECHEM
00338
+0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.93%
Sample Name
Sample Code
 +7.63%
Sample Name
Sample Code
 +6.59%
4
INESA Intelligent Tech Inc.
600602
+6.48%
5
Hand Enterprise Solutions
300170
+6.15%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -